ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2566

Hexokinase 2 As a Novel Metabolic Target for Rheumatoid Arthritis

Marta Fernandez Bustamante1, Ricard Garcia-Carbonell2, Jeffrey Smith2, Gary Firestein1, Shigeki Miyamoto2 and Monica Guma1, 1Medicine, UCSD, La Jolla, CA, 2Pharmacology, UCSD, La Jolla, CA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Fibroblasts, metabolism and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Rheumatoid Arthritis – Human Etiology and Pathogenesis - Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Hexokinases (HKs) catalyze the first step in glucose metabolism. HK2 constitutes the principal inducible isoform with a restricted distribution in normal adult tissues. Up-regulated glycolysis and HK2 expression have a powerful growth advantage, which promotes cell proliferation and invasion. Fibroblast-like synoviocytes (FLS) are a key component of rheumatoid arthritis (RA) invasive synovium, and display unique aggressive features, including increased migration and invasion. We have recently showed that RA FLS present an altered glucose metabolism, which modulates FLS mediated functions. To determine whether HK2 is a key regulator of FLS glycolytic and aggressive phenotype, we examined its role on FLS functions and in an arthritis animal model.

Methods: HK1 and HK2 expression were studied by immunohistochemistry (IHC) in RA and osteoarthritis (OA) synovial tissue. HK2 expression in FLS was studied by double IHC and qPCR in synovial tissue and FLS cell lines, respectively. RA FLS were transfected with HK2 siRNA, or infected with HK2 expressing adenovirus (ad) and the following FLS functions were conducted: migration (scratch assay) and matrigel invasion assay after PDGF stimulation, and metalloproteases (MMP) expression after LPS stimulation. We used HK2F/Fmice, harboring the ubiquitously expressed tamoxifen inducible Cre (UBCcreERT2) in order to systemically delete HK2. Passive KRN arthritis was induced injecting intraperitoneally 150μl of serum 3 weeks after tamoxifen treatment. Clinical scores were assessed daily and histopathological studies were carried on day 10.

Results:  While HK1 is widely expressed in both RA and OA synovial tissue, HK2 is particular of RA histopathology (9/9 RA; 3/9 OA). HK2 is localized in the synovial lining and sublining and it co-localizes with vimentin as a marker for FLS. Basal HK2 expression was increased in RA compared to OA FLS, and its expression increased after LPS and PDGF stimulation. Silencing HK2 in RA FLS resulted in a less invasive phenotype (3.2 fold less invaded area in HK2-silenced FLS, p<0.05) and lower levels of MMP3 expression. Consistently, overexpression of HK2 resulted in an increased ability to migrate (scratch length: GFP-ad: 299.1±7.2; HK2-ad 90.7±2.5; p<0.001) and invade (3.1 fold invaded area in HK2-ad; p<0.001). The UBCcre-HK2F/F mice showed lower clinical and histological arthritis scores than wild type mice (WT) (clinical score at day 10: WT: 9±0.79; UBCCre-HK2F/F: 3±0.49 (p<0.001)).

Conclusion: HK2 is more abundantly expressed in RA than OA synovial lining, and regulates FLS aggressive functions. HK2 also contributes to arthritis severity in the KRN animal model. Therefore, selective HK2 inhibition might be an attractive potential selective target safer than global glycolysis.


Disclosure: M. Fernandez Bustamante, None; R. Garcia-Carbonell, None; J. Smith, None; G. Firestein, None; S. Miyamoto, None; M. Guma, None.

To cite this abstract in AMA style:

Fernandez Bustamante M, Garcia-Carbonell R, Smith J, Firestein G, Miyamoto S, Guma M. Hexokinase 2 As a Novel Metabolic Target for Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/hexokinase-2-as-a-novel-metabolic-target-for-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hexokinase-2-as-a-novel-metabolic-target-for-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology